The Case of Congenital Combined Immunodeficiency with Severe Atopy: The Importance of Early Diagnosis and Features of Therapeutic Strategies
https://doi.org/10.37489/0235-2990-2024-69-9-10-56-60
EDN: HNYAYH
Abstract
The article describes a case of congenital combined immunodeficiency with severe atopy – deficiency of the cytogenesis regulator (DOCK8) The article examines modern ideas about the role of DOCK8 protein in ensuring the basic functions of the immune system, the consequences of loss of function of DOCK8 protein, epidemiology, clinical manifestations, modern principles of diagnosis and treatment of DOCK8 deficiency.
About the Authors
E. N. SerebryakovaRussian Federation
Elena N. Serebryakova — D. Sc. in Medicine, Associate Professor, Professor of the Department of Hospital Pediatrics
ResearcherID: ABG-8330-2021 ; Scopus Author ID: 36020648000
Chelyabinsk
Competing Interests:
Авторы заявляют об отсутствии конфликта интересов.
T. V. Shilova
Russian Federation
Tatiana V. Shilova
Scopus Author ID: 57211799427
Chelyabinsk
Competing Interests:
Авторы заявляют об отсутствии конфликта интересов.
A. S. Kozhevnikov
Russian Federation
Artem S. Kozhevnikov
ResearcherID: RID72103 ; Scopus Author ID: 58103491300
Chelyabinsk
Competing Interests:
Авторы заявляют об отсутствии конфликта интересов.
A. M. Razzhivin
Russian Federation
Artem M. Razzhivin
ResearcherID: LIF-4379-2024
Chelyabinsk
Competing Interests:
Авторы заявляют об отсутствии конфликта интересов.
References
1. Ravendran S., Hernández S. S., König S., Bak R. O. CRISPR/Cas-Based Gene Editing Strategies for DOCK8 Immunodeficiency Syndrome. Front Genome Ed. 2022 Mar 17;4:793010. doi: 10.3389/fgeed.2022.793010.
2. Liquidano-Pérez E., Maza-Ramos G., Yamazaki- Nakashimada M. A., Barragán-Arévalo T., Lugo- Reyes S. O., Scheffler-Mendoza S., EspinosaPadilla S. E., González- Serrano M. E. Combined immunodeficiency due to DOCK8 deficiency. State of the art. Rev Alerg Mex. 2022 Jul 1; 69 (1): 31–47. Spanish. doi: 10.29262/ram.v69i1.1104.
3. Momtazmanesh S., Rayzan E., Zoghi S., Shahkarami S., Molatefi R., Mohammadzadeh I., Ghaffari J., Mahmoudi H., Dmytrus J., Segarra-Roca A., Somekh I., Witzel M., Hauck F., Boztug K., Klein C., Rezaei N. Novel variants of DOCK8 deficiency in a case series of iranian patients. endocr metab immune disord drug targets. 2022; 22 (1): 159–168. doi: 10.2174/1871530321666210226143912.
4. Ollech A., Mashiah J., Lev A., Simon A. J., Somech R., Adam E., Barzilai A., Hagin D., Greenberger S. Treatment options for DOCK8 deficiencyrelated severe dermatitis. J Dermatol. 2021 Sep; 48 (9): 1386–1393. doi: 10.1111/1346-8138.15955.
5. Silbert S., Cole K., Bedoya S. Z., Freeman A. F., Whangbo J. S., Avila D. N., Su HC, Yates B., Epstein M., Wendler D. S., Pai S. Y., Hickstein D. D., Wiener L., Shah N. N. Tandem hematopoietic stem cell transplant considerations in families with multiple siblings affected by DOCK8 deficiency. Bone Marrow Transplant. 2022 Nov; 57 (11): 1721–1723. doi: 10.1038/s41409-022-01778-4.
6. Sams L., Wijetilleka S., Ponsford M., Gennery A., Jolles S. Atopic manifestations of inborn errors of immunity. Curr Opin Allergy Clin Immunol. 2023 Dec 1; 23 (6): 478–490. doi: 10.1097/ACI.0000000000000943.
7. Gracci S., Novelli T., D'Elios S, Bernardini R., Peroni D. Hyper IgE syndromes. Curr Pediatr Rev. 2024; 20 (3): 253–264. doi: 10.2174/1573396320666230912103124.
8. Kasap N., Kara A., Celik V., Bilgic Eltan S., Akay Haci I., Kose H., Aygun A., Akkelle E., Yakici N., Guner S. N., Reisli I., Keles S., Cekic S., Kilic S. S., Karaca N. E., Gulez N., Genel F., Ozen A., Yucelten A. D., Karakoc-Aydiner E., Schmitz-Abe K., Baris S. Atypical localization of eczema discriminates DOCK8 or stat3 deficiencies from atopic dermatitis. J Clin Immunol. 2023 Nov; 43 (8): 1882–1890. doi: 10.1007/s10875-023-01554-z.
9. Tangye S. G., Gray P. E., Pillay B. A., Yap J. Y., Figgett W. A., Reeves J., Kummerfeld S. K., Stoddard J., Uzel G., Jing H., Su H. C., Campbell D. E., Sullivan A., Burnett L., Peake J., Ma C. S. Hyper-IgE syndrome due to an elusive novel intronic homozygous variant in DOCK8. J Clin Immunol. 2022 Jan; 42 (1): 119–129. doi: 10.1007/s10875-021-01152-x.
10. Shakerian L., Nourizadeh M., Badalzadeh M., Fazlollahi M. R., Shokouhi Shoormasti R., Saghafi S., Esmaeili B., Alizadeh Z., Borte S., Houshmand M., Hammarström L., Pourpak Z. Investigating the variation of TREC/KREC in combined immunodeficiencies. Iran J Allergy Asthma Immunol. 2021 Aug 7; 20 (4): 402–412.
11. Dasouki M., Jabr A., AlDakheel G., Elbadaoui F., Alazami A. M., AlSaud B., Arnaout R., Aldhekri H., Alotaibi I., Al-Mousa H., Hawwari A. TREC and KREC profiling as a representative of thymus and bone marrow output in patients with various inborn errors of immunity. Clin Exp Immunol. 2020 Oct; 202 (1): 60–71. doi: 10.1111/cei.13484.
Review
For citations:
Serebryakova E.N., Shilova T.V., Kozhevnikov A.S., Razzhivin A.M. The Case of Congenital Combined Immunodeficiency with Severe Atopy: The Importance of Early Diagnosis and Features of Therapeutic Strategies. Antibiot Khimioter = Antibiotics and Chemotherapy. 2024;69(9-10):56-60. (In Russ.) https://doi.org/10.37489/0235-2990-2024-69-9-10-56-60. EDN: HNYAYH